CA2029419C - Nmda-blocking pharmaceutical compositions - Google Patents

Nmda-blocking pharmaceutical compositions Download PDF

Info

Publication number
CA2029419C
CA2029419C CA002029419A CA2029419A CA2029419C CA 2029419 C CA2029419 C CA 2029419C CA 002029419 A CA002029419 A CA 002029419A CA 2029419 A CA2029419 A CA 2029419A CA 2029419 C CA2029419 C CA 2029419C
Authority
CA
Canada
Prior art keywords
composition according
designates
treatment
compound
chained
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA002029419A
Other languages
English (en)
French (fr)
Other versions
CA2029419A1 (en
Inventor
Yoel Kloog
Jeffery J. Feigenbaum
Raphael Mechoulam
Mordechai Sokolowsky
Simon Benita
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ramot at Tel Aviv University Ltd
Yissum Research Development Co of Hebrew University of Jerusalem
Original Assignee
Ramot at Tel Aviv University Ltd
Yissum Research Development Co of Hebrew University of Jerusalem
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ramot at Tel Aviv University Ltd, Yissum Research Development Co of Hebrew University of Jerusalem filed Critical Ramot at Tel Aviv University Ltd
Publication of CA2029419A1 publication Critical patent/CA2029419A1/en
Application granted granted Critical
Publication of CA2029419C publication Critical patent/CA2029419C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78—Ring systems having three or more relevant rings
    • C07D311/80—Dibenzopyrans; Hydrogenated dibenzopyrans

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Toxicology (AREA)
  • Hospice & Palliative Care (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrane Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
CA002029419A 1989-11-07 1990-11-07 Nmda-blocking pharmaceutical compositions Expired - Fee Related CA2029419C (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IL92238 1989-11-07
IL9223889A IL92238A (en) 1989-11-07 1989-11-07 ADMN blocking product containing tetrahydrocannabinol history, several new tetrahydrocannabinol histories and process for their preparation

Publications (2)

Publication Number Publication Date
CA2029419A1 CA2029419A1 (en) 1991-05-08
CA2029419C true CA2029419C (en) 2004-05-25

Family

ID=11060554

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002029419A Expired - Fee Related CA2029419C (en) 1989-11-07 1990-11-07 Nmda-blocking pharmaceutical compositions

Country Status (11)

Country Link
EP (1) EP0427518B1 (en:Method)
JP (1) JPH0768235B2 (en:Method)
KR (1) KR950005914B1 (en:Method)
AT (1) ATE119898T1 (en:Method)
AU (1) AU631262B2 (en:Method)
CA (1) CA2029419C (en:Method)
DE (1) DE69017839T2 (en:Method)
DK (1) DK0427518T3 (en:Method)
ES (1) ES2071786T3 (en:Method)
IL (1) IL92238A (en:Method)
ZA (1) ZA908914B (en:Method)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6017903A (en) 1996-09-27 2000-01-25 Guilford Pharmaceuticals Inc. Pharmaceutical compositions and methods of treating a glutamate abnormality and effecting a neuronal activity in an animal using NAALADase inhibitors
US5824662A (en) 1996-09-27 1998-10-20 Guilford Pharmaceuticals Inc. Treatment of global and focal ischemia using naaladase inhibitors
CN1230889A (zh) 1996-09-27 1999-10-06 吉尔福特药业有限公司 NAALADase组合物和治疗谷氨酸异常及在动物中产生神经元活性的方法
DE19706903A1 (de) * 1997-02-21 1998-08-27 Bayer Ag Verwendung von bekannten Agonisten des zentralen Cannabinoid-Rezeptors CB 1
WO1998050027A1 (en) * 1997-05-07 1998-11-12 Unimed Pharmaceutical, Inc. Method of improving disturbed behavior and elevating mood in humans
AU766988B2 (en) * 1998-04-21 2003-10-30 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Cannabinoids as antioxidants and neuroprotectants
CA2623723A1 (en) 2005-09-29 2007-04-12 Amr Technology, Inc. Process for production of delta-9-tetrahydrocannabinol
DE102015112092B4 (de) 2015-07-24 2022-03-10 Beko Technologies Gmbh Öl/Wasser-Trennvorrichtung mit Druckluftbeaufschlagung

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL48824A (en) * 1976-01-12 1980-05-30 Yissum Res Dev Co Pharmaceutical compositions containing (3s,js) tetrahydrocanabinol derivatives and some novel compounds of this type
US4133819A (en) * 1977-06-17 1979-01-09 Pfizer Inc. Hexahydro-1-hydroxy-9-hydroxymethyl-3-substituted-6H-dibenzo[b,d]pyrans as analgesic agents
US4209520A (en) * 1977-06-17 1980-06-24 Pfizer Inc. Hexahydro-1-hydroxy-9-hydroxymethyl-3-substituted-6H-dibenzo[b,d]pyrans as analgesic agents
IL80411A (en) * 1986-10-24 1991-08-16 Raphael Mechoulam Preparation of dibenzopyranol derivatives and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
JPH0768235B2 (ja) 1995-07-26
AU631262B2 (en) 1992-11-19
AU6583490A (en) 1991-05-30
KR910009687A (ko) 1991-06-28
ES2071786T3 (es) 1995-07-01
KR950005914B1 (ko) 1995-06-07
IL92238A (en) 1995-07-31
CA2029419A1 (en) 1991-05-08
ATE119898T1 (de) 1995-04-15
EP0427518A1 (en) 1991-05-15
IL92238A0 (en:Method) 1990-07-26
DE69017839T2 (de) 1995-08-31
DK0427518T3 (da) 1995-07-24
ZA908914B (en) 1991-09-25
JPH03209377A (ja) 1991-09-12
EP0427518B1 (en) 1995-03-15
DE69017839D1 (de) 1995-04-20

Similar Documents

Publication Publication Date Title
US5284867A (en) NMDA-blocking pharmaceutical compositions
EP1299374B1 (en) Novel non-psychotropic cannabinoids
US6331560B1 (en) Tumor necrosis factor alpha (TNF-α) inhibiting pharmaceuticals
US6117844A (en) Method and composition for antiviral therapy
US20090306221A1 (en) Use for Cannabinoid
WO2022129908A1 (en) Cannabinoid derivative as a pharmaceutically active compound and method of preparation thereof
US8513299B2 (en) Methods of using low-dose doxepin for the improvement of sleep
US20090042972A1 (en) Methods of using low-dose doxepin for the improvement of sleep
US20070213369A1 (en) Novel non-psychotropic cannabinoids
CA2029419C (en) Nmda-blocking pharmaceutical compositions
US20040087664A1 (en) Methods and compositions for treatment of macular and retinal disease
CA2507815A1 (en) High enantiomeric purity dexanabinol for pharmaceutical compositions
JPS58500995A (ja) 緑内障治療用組成物
EP1802293A2 (en) Orally effective cannabinoid analogs
US20220168265A1 (en) Pharmaceutical composition comprising tetrahydrocannabivarin for the prevention and treatment of overweight
JP2025514339A (ja) 疾患の処置に使用するための組成物
EP1785417A2 (en) Novel non-psychotropic cannabinoids
JPH05331146A (ja) 新規ジテルペンアルカロイド及びジテルペンアルカロイド類を有効成分とする心疾患治療薬
JPH07179340A (ja) モノアミンオキシダーゼ阻害剤
WO1991012004A1 (en) Topical use of 6-n-butyl-1,4,7,10-tetrahydro-4,10-dioxo-1,7-phenanthroline-2,8-dicarboxylic acid derivatives
JPH11100377A (ja) Ｈｉｖプロテアーゼ阻害物質

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed